These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Relationship Between Blood Dyscrasias and Retinopathies]. AGATSTON SA Arch Oftalmol B Aires; 1945; 20():320-2. PubMed ID: 21007807 [No Abstract] [Full Text] [Related]
44. Association of capillary density and function measures with blood pressure, fasting plasma glucose, and insulin sensitivity. Cheng C; Daskalakis C; Falkner B J Clin Hypertens (Greenwich); 2010 Feb; 12(2):125-35. PubMed ID: 20167040 [TBL] [Abstract][Full Text] [Related]
45. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Stefansson E; Landers MB; Wolbarsht ML Ophthalmic Surg; 1983 Mar; 14(3):209-26. PubMed ID: 6190118 [TBL] [Abstract][Full Text] [Related]
46. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model. Wolbarsht ML; Landers MB Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650 [TBL] [Abstract][Full Text] [Related]
48. Retinal neovascularization. WISE GN Trans Am Ophthalmol Soc; 1956; 54():729-826. PubMed ID: 13433795 [No Abstract] [Full Text] [Related]
49. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. ASHTON N; WARD B; SERPELL G Br J Ophthalmol; 1954 Jul; 38(7):397-432. PubMed ID: 13172417 [No Abstract] [Full Text] [Related]
51. Inhibition of neovascularization by an extract derived from vitreous. Preis I; Langer R; Brem H; Folkman J Am J Ophthalmol; 1977 Sep; 84(3):323-8. PubMed ID: 900228 [TBL] [Abstract][Full Text] [Related]
52. Inhibitors of neovascularization in relation to diabetic and other proliferative retinopathies. Patz A; Lutty G; Bennett A; Coughlin WR Trans Am Ophthalmol Soc; 1978; 76():102-7. PubMed ID: 754366 [TBL] [Abstract][Full Text] [Related]